These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 17498575)
1. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective? Beller GA J Am Coll Cardiol; 2007 May; 49(19):1918-23. PubMed ID: 17498575 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of silent coronary artery disease in type 2 diabetes. Zellweger MJ Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561 [TBL] [Abstract][Full Text] [Related]
4. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666 [TBL] [Abstract][Full Text] [Related]
5. The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Anand DV; Lim E; Lahiri A; Bax JJ Eur Heart J; 2006 Apr; 27(8):905-12. PubMed ID: 16087647 [TBL] [Abstract][Full Text] [Related]
6. Screening for coronary artery disease in patients with diabetes. Bax JJ; Young LH; Frye RL; Bonow RO; Steinberg HO; Barrett EJ; Diabetes Care; 2007 Oct; 30(10):2729-36. PubMed ID: 17901530 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker. Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328 [TBL] [Abstract][Full Text] [Related]
8. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK; Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744 [TBL] [Abstract][Full Text] [Related]
9. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. Berman DS; Hachamovitch R; Shaw LJ; Friedman JD; Hayes SW; Thomson LE; Fieno DS; Germano G; Wong ND; Kang X; Rozanski A J Nucl Med; 2006 Jul; 47(7):1107-18. PubMed ID: 16818945 [TBL] [Abstract][Full Text] [Related]
10. Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study. Vanzetto G; Boizel R; Halimi S; Ormezzano O; Belle L; Fagret D; Machecourt J Diabetes Metab; 2007 Dec; 33(6):459-65. PubMed ID: 17977767 [TBL] [Abstract][Full Text] [Related]
11. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Valensi P; Cosson E Diabetes Metab; 2010 Apr; 36(2):91-6. PubMed ID: 20189425 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic impact of screening for myocardial ischemia among asymptomatic type 2 diabetic subjects]. Wallemacq CM; Scheen AJ Rev Med Suisse; 2008 Aug; 4(168):1800-4. PubMed ID: 18814763 [TBL] [Abstract][Full Text] [Related]
13. [Strategy of investigation of coronary artery disease in diabetes: from screening to suspicion of acute coronary syndromes]. Machecourt J; Vanzetto G; Fagret D Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():41-6. PubMed ID: 15666481 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of ischemia]. Kurz K; Katus HA; Giannitsis E Herz; 2004 Sep; 29(6):575-81. PubMed ID: 15912431 [TBL] [Abstract][Full Text] [Related]
15. [In type 2 diabetic patients look for silent myocardial ischemia. Yes, but only after preselection]. Grooterhorst P MMW Fortschr Med; 2005 Jun; 147(25):17. PubMed ID: 16038334 [No Abstract] [Full Text] [Related]
16. [Silent myocardial ischemia in diabetic patients: to screen or not to screen?]. Meyer P Rev Med Suisse; 2005 Jun; 1(22):1505-7, 1509-10. PubMed ID: 16025890 [TBL] [Abstract][Full Text] [Related]
17. [Prevention of coronary artery disease. Role of noninvasive imaging]. Knez A Herz; 2007 Aug; 32(5):395-403. PubMed ID: 17687529 [TBL] [Abstract][Full Text] [Related]
18. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Choi EK; Koo BK; Kim HS; Cho YM; Kang HJ; Cho YS; Chung WY; Chae IH; Choi DJ; Oh BH; Park YB; Choi YS Diabet Med; 2007 Sep; 24(9):1003-11. PubMed ID: 17509072 [TBL] [Abstract][Full Text] [Related]
20. The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes. Rutter MK; Nesto RW Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):26-35. PubMed ID: 17179927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]